(C) World Health Organization
This story was originally published by World Health Organization and is unaltered.
. . . . . . . . . .



WHO Consultation on the Composition of Influenza Virus Vaccines for Use in the 2024-2025 Northern Hemisphere Influenza Season [1]

[]

Date: 2024-02-19

WHO Consultation

Background

The periodic replacement of viruses contained in influenza vaccines is necessary in order for the vaccines to be effective due to the constant evolving nature of influenza viruses, including those circulating and infecting humans.

Twice annually, WHO organizes consultations with an advisory group of experts to analyze influenza virus surveillance data generated by the WHO Global Influenza Surveillance and Response System (GISRS), and issues recommendations on the composition of the influenza vaccines for the following influenza season. These recommendations are used by the national vaccine regulatory agencies and the pharmaceutical companies to develop, produce and license influenza vaccines.

Objectives

Analyze the antigenic and genetic characteristics of seasonal influenza viruses circulating and infecting humans, taking into consideration the available epidemiological and clinical information from individual countries and regions;

Make recommendations on the composition of influenza virus vaccines for use in the 2024-2025 northern hemisphere influenza season;

Review the antigenic and genetic characteristics of recent A(H7N9) and A(H5) viruses that the WHO Collaborating Centres of the GISRS received and the need to develop new A(H7N9) and A(H5) candidate vaccine viruses for pandemic preparedness purposes; and

Review the antigenic and genetic characteristics of other subtype or variant influenza viruses infecting humans recently, and the need to develop new candidate vaccine viruses for pandemic preparedness purposes.

Participants (by invitation)

Representatives from WHO Collaborating Centres for influenza (CCs) of GISRS;

Representatives from WHO Essential Regulatory Laboratories (ERLs) of GISRS;

Representatives from National Influenza Centres and WHO H5 Reference Laboratories of GISRS;

Representatives from the WHO Collaborating Centre for Modelling, Evolution, and Control of Emerging Infectious Diseases; and

Representatives from the OIE/FAO Network of expertise on animal influenza (OFFLU).

Provisional main agenda items

[END]
---
[1] Url: https://www.who.int/news-room/events/detail/2024/02/19/default-calendar/who-consultation-on-the-composition-of-influenza-virus-vaccines-for-use-in-the-2024-2025-northern-hemisphere-influenza-season

Published and (C) by World Health Organization
Content appears here under this condition or license: Creative Commons CC-BY-NC-SA 3.0 IGO.

via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/who/

You are viewing proxied material from magical.fish. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.